Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02978677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas

Study acronym: PANAMA
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Primary completion date: Dec 2027 to Dec 2028
    • Start date: Oct 2019 to Oct 2022
    • Study completion date: Dec 2028 to Dec 2029
    v4
  3. Start date: Jan 2018 to Oct 2019v3
  4. Phase: Phase 2 to Not applicable
    • Primary completion date: Dec 2026 to Dec 2027
    • Start date: Jan 2017 to Jan 2018
    • Study completion date: Dec 2027 to Dec 2028
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The trial evaluates the effect of a moderately increased radiation dose in patients with atypical (grade II) and anaplastic (grade III) meningioma after incomplete or no surgery. Endpoint is recurrence-free survival after 5 years.
Trial Details
NCT Number NCT02978677
Lead Sponsor Technische Universität Dresden
Collaborators: German Cancer Research Center, Radiation Oncology Working Group of the German Cancer Society
Conditions
(from sponsor)		 Meningioma
Related terms Brain Neoplasms, Meningioma
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov